Pipeline
PTS Indication

Severe Malignant Airway Obstruction

Hepatocellular Carcinoma

Adenoid cystic carcinoma

Malignant pleural effusion
Pre-clinical phase
Clinical phase I
Clinical phase II
Clinical phase III
NDA Submission
Market Approval
 
 
 
 
 
 
 
New product

New ingredient development

New ingredient development
Pre-clinical phase
Clinical phase I
Clinical phase II
Clinical phase III
NDA Submission
Market Approval